Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women

Gynecological Endocrinology

Volumn 14, Issue 2, 2000, Pages 142-146

  Piccinini, F ^a   Rovati, L ^b   Zanni, A ^a   Cagnacci, A ^a   Volpe, A ^a   Facchinetti, F ^a,c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Rotta Research Laboratorium   (Italy)

^c Clinica Ostetrica e Ginecologica   (Italy)

Author keywords

Arginine; Citrulline; Estrogen replacement therapy; Menopause; Nitric oxide

Indexed keywords

ARGININE; CITRULLINE; DERMESTRIL 50; ESTRADIOL; ESTROGEN; FOLLITROPIN; INSULIN; NITRIC OXIDE SYNTHASE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENZYME ACTIVITY; ESTROGEN THERAPY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034124081     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513590009167673     Document Type: Article

References (15)

1. 1. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-62
2. 2. Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-204
3. 3. Hayashi T, Fukuto JM, Ignarro LJ, et al. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA 1992;89: 11259-63
4. 4. Hishikawa K, Nakaki T, Marumo T, et al. Induction of constitutive nitric oxide synthase by estradiol in human endothelial cells. Hypertension 1994;24:386
5. 5. Van-Buren GA, Yang DS, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 1992;167: 828-33
6. 6. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-39
7. 7. Crook D. The metabolic consequences of treating postmenopausal women with non-oral hormone replacement therapy. Br J Obstet Gynaecol 1997;104 (Suppl 16):4-13
8. 8. Cicinelli E, Ignarro LJ, Lograno M, et al. Effects of short-term transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil Steril 1998;69:58-61
9. 9. Rosselli M, Imthurn B, Keller PJ, et al. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. Hypertension 1995;25: 848-53
10. 10. Imthurn D, Rosselli M, Jaeger AW, et al. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. J Clin Endocrinol Metab 1997;82:388-94
11. 11. Best PJM, Berger PB, Miller VM, et al. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 1998;128:285-8
12. 12. Verdernikov YP, Liao QP, Jain V, et al. Effect of chronic treatment with 17β-estradiol and progesterone on endothelium-dependent and endothelium-independent relaxation in isolated aortic rings from ovariectomized rats. Am J Obstet Gynecol 1997;176:603-8
13. 13. Binko J, Murphy TV, Majewski H. 17β-estradiol enhances nitric oxide synthase activity in endothelium-denuded aorta. Clin Exp Pharmacol Physiol 1998;25:120-7
14. 14. Lydrup ML, Nilsson BO. Acute and long-term effects of 17β-estradiol on agonist-stimulated force in rat tail artery. Acta Physiol Scand 1996;158:253-9
15. 15. Corbett JA, McDaniel ML. The role of nitric oxide in autoimmune diabetes. In Lancaster J, ed. Nitric Oxide: Principles and Actions. San Diego, CA: Academic Press Inc., 1996